JP2023509849A5 - - Google Patents
Info
- Publication number
- JP2023509849A5 JP2023509849A5 JP2022535595A JP2022535595A JP2023509849A5 JP 2023509849 A5 JP2023509849 A5 JP 2023509849A5 JP 2022535595 A JP2022535595 A JP 2022535595A JP 2022535595 A JP2022535595 A JP 2022535595A JP 2023509849 A5 JP2023509849 A5 JP 2023509849A5
- Authority
- JP
- Japan
- Prior art keywords
- neutrophils
- treating cancer
- cancer
- reference standard
- unsuitable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1918313.6 | 2019-12-12 | ||
| GBGB1918313.6A GB201918313D0 (en) | 2019-12-12 | 2019-12-12 | Cells for treating cancer |
| PCT/GB2020/053199 WO2021116713A1 (en) | 2019-12-12 | 2020-12-11 | Cells for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509849A JP2023509849A (ja) | 2023-03-10 |
| JP2023509849A5 true JP2023509849A5 (enExample) | 2023-12-12 |
Family
ID=69186690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535595A Pending JP2023509849A (ja) | 2019-12-12 | 2020-12-11 | 癌を処置するための細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230203441A1 (enExample) |
| EP (1) | EP4073509A1 (enExample) |
| JP (1) | JP2023509849A (enExample) |
| CN (1) | CN115136005A (enExample) |
| AU (1) | AU2020402167A1 (enExample) |
| BR (1) | BR112022011349A2 (enExample) |
| CA (1) | CA3173535A1 (enExample) |
| GB (1) | GB201918313D0 (enExample) |
| IL (1) | IL293740A (enExample) |
| WO (1) | WO2021116713A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201618106D0 (en) | 2016-10-26 | 2016-12-07 | Lift Biosciences Ltd | Cancer-killing cells |
| WO2024189333A1 (en) | 2023-03-10 | 2024-09-19 | Lift Biosciences Ltd | Immunomodulatory cells and compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| US9199028B2 (en) * | 2010-01-15 | 2015-12-01 | Memorial Sloan-Kettering Cancer Center | Use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients |
| WO2016020530A1 (en) * | 2014-08-07 | 2016-02-11 | Reponex Pharmaceuticals Aps | Compositions for the treatment of periotonitis |
-
2019
- 2019-12-12 GB GBGB1918313.6A patent/GB201918313D0/en not_active Ceased
-
2020
- 2020-12-11 CN CN202080096399.1A patent/CN115136005A/zh active Pending
- 2020-12-11 JP JP2022535595A patent/JP2023509849A/ja active Pending
- 2020-12-11 AU AU2020402167A patent/AU2020402167A1/en active Pending
- 2020-12-11 WO PCT/GB2020/053199 patent/WO2021116713A1/en not_active Ceased
- 2020-12-11 EP EP20839137.5A patent/EP4073509A1/en active Pending
- 2020-12-11 US US17/785,012 patent/US20230203441A1/en active Pending
- 2020-12-11 BR BR112022011349A patent/BR112022011349A2/pt unknown
- 2020-12-11 IL IL293740A patent/IL293740A/en unknown
- 2020-12-11 CA CA3173535A patent/CA3173535A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA | |
| Schneider et al. | Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 | |
| Bakri et al. | Balance of MafB and PU. 1 specifies alternative macrophage or dendritic cell fate | |
| Chapellier et al. | Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response | |
| FI3835415T3 (fi) | Menetelmä cd3-positiivisen solun tuottamiseksi | |
| de Haar et al. | Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation | |
| JP2023509849A5 (enExample) | ||
| Teo et al. | Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma | |
| Zhang et al. | Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells | |
| Zhan et al. | Single‐cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism‐related mechanisms | |
| Nedelkovska et al. | Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node | |
| JP7025524B2 (ja) | 非動員末梢血を利用した不均一性造血幹細胞・前駆細胞の製造方法 | |
| Belay et al. | Human cord blood and bone marrow CD34+ cells generate macrophages that support erythroid islands | |
| Yoshikawa et al. | Characterization of CD133+ parenchymal cells in the liver: Histology and culture | |
| Signoretto et al. | Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis | |
| Zhang et al. | IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/PTGS2 pathway | |
| JP2021500081A5 (enExample) | ||
| Meng et al. | Plac1+ Tumor Cell‐Treg Interplay Supports Tumorigenesis and Progression of Head and Neck Cancer | |
| CN119372160A (zh) | 源自ido1基因的hla-a*11:01肾细胞癌肿瘤抗原短肽 | |
| Hernandez‐Fernaud et al. | Quantitative mass spectrometry‐based proteomics in angiogenesis | |
| CN102876632B (zh) | 人nk/t细胞系 | |
| CN107236709B (zh) | 来源于肺转移灶的高转移人卵巢癌细胞系及其建立和应用 | |
| CN112451662A (zh) | 一种gli蛋白抑制剂及其应用 | |
| CN113493767A (zh) | 利用人多潜能干细胞体外制备嗜酸性粒细胞 | |
| Al-Khalaf et al. | Interleukin-8 dedifferentiates primary human luminal cells to multipotent stem cells |